Abstract
Background and importanceSecukinumab is an immunoglobulin G1 monoclonal antibody that selectively binds to interleukin 17A and inhibits its interaction with the IL-A receptor. It is indicated in psoriasis (Ps), psoriatic...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have